SEC Form 4 Summary VRTX

Vertex director Nancy Thornberry sells $547,860 in VRTX shares

Vertex Pharmaceuticals director Nancy Thornberry sold 1,000 VRTX shares for $547,860 on November 16, 2026.

Transaction Value:
$547,860.00
Shares transacted:
1,000
Average price:
$547.86
Insider:

The Form 4 filing was filed on November 18, 2026, two days after the November 16 sale. Form 4 is an SEC report of changes in an insider's stock ownership.

The filing information also notes a Rule 10b5-1 trading plan. Such plans set trading instructions in advance. The available details do not confirm whether that plan covered this sale.

Transaction details

Transaction
Date of Earliest Transaction2026-11-16
Date of Latest Transaction2026-11-16
Buy/Sellsell
Transaction Count1
Shares Transacted1,000
Price$547.86
Total Transaction Value$547,860.00
Insider
Ticker SymbolVRTX
CompanyVERTEX PHARMACEUTICALS INC / MA
Insider NameThornberry Nancy
Insider TitleDirector
Sector - IndustryHealthcare - Biotechnology
Holdings
Total Shares Owned After Transaction1,109
Position Size Change47.42%
Filing
Filing Date2026-11-18
SEC LinkView filing

FAQ

What type of transaction is this?

This was a sale of Vertex Pharmaceuticals (VRTX) shares by director Nancy Thornberry. The report lists one transaction with code S, the SEC code for a share sale.

What was the average price of the transaction?

The average sale price was $547.86 per share. That average applies to the 1,000 shares in the reported sale.

How did this transaction affect the insider's holdings?

The sale left Nancy Thornberry with 1,109 reported shares. She sold 1,000 shares, or 47.42% of the shares she owned before the sale.

What's the total transaction value?

The total reported transaction value was $547,860.00. That is the value of the single sale listed in this filing.

Are there any special circumstances around this transaction?

The filing information includes a Rule 10b5-1 plan notice, but its scope is unclear from the available details. Such a notice may cover the filing as a whole. No footnote text is available to confirm whether this sale was covered by the plan. The plan's start date and trading schedule are also unknown.

For research purposes only; not investment advice.

Follow the Newswire
Feedly RSS feed
About RSS

Get new articles in your feed reader as they are published. Add our RSS feed to Feedly or another RSS reader.

Instant SEC Form 4 alerts

Get the next insider trade alert in real time.

Follow the filings behind the headlines. Get matching insider trade alerts sent straight to your email or Telegram, with links to the original SEC filings. Choose Premium for instant alert delivery and ticker-level filters.

Try instant alerts free 10 trading days · No credit card required

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
  • 20 years of alert history
  • Live alert directory updates
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and SEC filing links
  • Access to the alert directory hourly refreshes
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

  • Everything in Standard
  • Instant delivery detection-to-outbound time averages 0.60 seconds
  • Alert intervals starting from one minute
  • Real time alert directory updates
Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.